These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38606953)

  • 1. Monitoring for liver cancer post-gene therapy-How much and how often?
    P de Jong Y; Jacobson IM
    J Viral Hepat; 2024 Apr; 31 Suppl 1():35-40. PubMed ID: 38606953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.
    Hadi M; Qutaiba B Allela O; Jabari M; Jasoor AM; Naderloo O; Yasamineh S; Gholizadeh O; Kalantari L
    Virol J; 2024 Jan; 21(1):17. PubMed ID: 38216938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration and the risk of liver cancer-Is there a real risk?
    Kasimsetty A; Sabatino DE
    J Viral Hepat; 2024 Apr; 31 Suppl 1():26-34. PubMed ID: 38606944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
    Chandler RJ; LaFave MC; Varshney GK; Trivedi NS; Carrillo-Carrasco N; Senac JS; Wu W; Hoffmann V; Elkahloun AG; Burgess SM; Venditti CP
    J Clin Invest; 2015 Feb; 125(2):870-80. PubMed ID: 25607839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.
    Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF
    World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV Infection: Protection from Cancer.
    Srivastava A; Carter BJ
    Hum Gene Ther; 2017 Apr; 28(4):323-327. PubMed ID: 27832705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.
    Dhungel B; Jayachandran A; Layton CJ; Steel JC
    Drug Deliv; 2017 Nov; 24(1):289-299. PubMed ID: 28165834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis.
    Schäffer AA; Dominguez DA; Chapman LM; Gertz EM; Budhu A; Forgues M; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Wu X; Bayarsaikhan E; Harris CC; Ruchirawat M; Ruppin E; Wang XW
    BMC Genomics; 2021 Nov; 22(1):814. PubMed ID: 34763675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV vector integration sites in mouse hepatocellular carcinoma.
    Donsante A; Miller DG; Li Y; Vogler C; Brunt EM; Russell DW; Sands MS
    Science; 2007 Jul; 317(5837):477. PubMed ID: 17656716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents.
    Peng D; Qian C; Sun Y; Barajas MA; Prieto J
    J Hepatol; 2000 Jun; 32(6):975-85. PubMed ID: 10898318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for haemophilia: a long and winding road.
    High KA
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():2-11. PubMed ID: 21781236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.
    Baruteau J; Waddington SN; Alexander IE; Gissen P
    J Inherit Metab Dis; 2017 Jul; 40(4):497-517. PubMed ID: 28567541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in delivery vectors for gene therapy in liver cancer.
    Redd Bowman KE; Lu P; Vander Mause ER; Lim CS
    Ther Deliv; 2020 Jan; 11(1):833-850. PubMed ID: 31840560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B.
    Schmidt M; Foster GR; Coppens M; Thomsen H; Dolmetsch R; Heijink L; Monahan PE; Pipe SW
    Blood Adv; 2023 Sep; 7(17):4966-4969. PubMed ID: 37352263
    [No Abstract]   [Full Text] [Related]  

  • 15. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.
    Ling C; Lu Y; Cheng B; McGoogan KE; Gee SW; Ma W; Li B; Aslanidi GV; Srivastava A
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
    George LA; Ragni MV; Rasko JEJ; Raffini LJ; Samelson-Jones BJ; Ozelo M; Hazbon M; Runowski AR; Wellman JA; Wachtel K; Chen Y; Anguela XM; Kuranda K; Mingozzi F; High KA
    Mol Ther; 2020 Sep; 28(9):2073-2082. PubMed ID: 32559433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of haemophilia gene therapy.
    High KH; Nathwani A; Spencer T; Lillicrap D
    Haemophilia; 2014 May; 20 Suppl 4():43-9. PubMed ID: 24762274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia.
    Peyvandi F; Garagiola I
    Haemophilia; 2019 Sep; 25(5):738-746. PubMed ID: 31282050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilia gene therapy: From trailblazer to gamechanger.
    Evens H; Chuah MK; VandenDriessche T
    Haemophilia; 2018 May; 24 Suppl 6():50-59. PubMed ID: 29878653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.